The UK Department of Health and NHS England have commissioned scientists to research the long-term impact of the pregnancy drug diethylstilbestrol (DES) [1].
This initiative follows an ITV News investigation that highlighted the multigenerational effects of the drug. The move comes as affected women continue to call for a full government inquiry into the scandal [1, 2].
To coordinate the effort, the Department of Health and NHS England have established a dedicated working group [1]. Researchers at Exeter University will be involved in the scientific study to determine how the drug affected patients and their offspring [1, 3].
DES was once widely administered to pregnant women to prevent miscarriages. Records indicate the drug was taken by millions worldwide [3]. While the drug was intended to protect pregnancies, it has been linked to severe health complications in the women who took it and their children, known as DES daughters and sons.
The current research push is a response to the ongoing trauma and health struggles of these families. The investigation by ITV News brought renewed attention to the case, prompting the government to engage with the scientific community to understand the full scope of the damage [1, 2].
Officials have not yet specified the exact timeline for the findings or whether the research will lead to a formal public inquiry. However, the involvement of Exeter University suggests a focus on clinical and longitudinal data to map the drug's lasting biological legacy [1, 3].
“The UK Department of Health and NHS England have commissioned scientists to research the long-term impact of the pregnancy drug diethylstilbestrol (DES).”
The establishment of a formal working group and the involvement of Exeter University signal a shift from anecdotal reporting to a structured medical evaluation of DES. By focusing on the multigenerational impact, the UK government is addressing a long-standing gap in public health accountability regarding synthetic hormones used in mid-century medicine.
